NCT06573164View on ClinicalTrials.gov

Allergic Rhinitis With/Without Asthma: Pre- and Post-Qipian Analysis

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Rhinitis, AllergicAsthma
Interventions
DRUG

Bacillus clausii tablets（Qipian®）

Take 4 tablets (0.3 mg each) orally three times daily.

DRUG

conventional medication

Use conventional medication as needed based on the patient's condition.

Trial Locations (1)

310009

The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT06573164 - Allergic Rhinitis With/Without Asthma: Pre- and Post-Qipian Analysis | Biotech Hunter | Biotech Hunter